JP2022062153A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022062153A5 JP2022062153A5 JP2022014339A JP2022014339A JP2022062153A5 JP 2022062153 A5 JP2022062153 A5 JP 2022062153A5 JP 2022014339 A JP2022014339 A JP 2022014339A JP 2022014339 A JP2022014339 A JP 2022014339A JP 2022062153 A5 JP2022062153 A5 JP 2022062153A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- dulaglutide
- composition according
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024021637A JP2024056908A (ja) | 2017-11-21 | 2024-02-16 | デュラグルチドを使用する方法およびデュラグルチドを含有する組成物 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762589244P | 2017-11-21 | 2017-11-21 | |
| US62/589,244 | 2017-11-21 | ||
| JP2020525974A JP7221956B2 (ja) | 2017-11-21 | 2018-11-13 | デュラグルチドを使用する方法およびデュラグルチドを含有する組成物 |
| PCT/US2018/060716 WO2019103875A2 (en) | 2017-11-21 | 2018-11-13 | Methods of using and compositions containing dulaglutide |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020525974A Division JP7221956B2 (ja) | 2017-11-21 | 2018-11-13 | デュラグルチドを使用する方法およびデュラグルチドを含有する組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024021637A Division JP2024056908A (ja) | 2017-11-21 | 2024-02-16 | デュラグルチドを使用する方法およびデュラグルチドを含有する組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022062153A JP2022062153A (ja) | 2022-04-19 |
| JP2022062153A5 true JP2022062153A5 (https=) | 2023-02-10 |
| JP7818412B2 JP7818412B2 (ja) | 2026-02-20 |
Family
ID=64572530
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020525974A Active JP7221956B2 (ja) | 2017-11-21 | 2018-11-13 | デュラグルチドを使用する方法およびデュラグルチドを含有する組成物 |
| JP2022014339A Active JP7818412B2 (ja) | 2017-11-21 | 2022-02-01 | デュラグルチドを使用する方法およびデュラグルチドを含有する組成物 |
| JP2024021637A Pending JP2024056908A (ja) | 2017-11-21 | 2024-02-16 | デュラグルチドを使用する方法およびデュラグルチドを含有する組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020525974A Active JP7221956B2 (ja) | 2017-11-21 | 2018-11-13 | デュラグルチドを使用する方法およびデュラグルチドを含有する組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024021637A Pending JP2024056908A (ja) | 2017-11-21 | 2024-02-16 | デュラグルチドを使用する方法およびデュラグルチドを含有する組成物 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US11576950B2 (https=) |
| EP (1) | EP3713593A2 (https=) |
| JP (3) | JP7221956B2 (https=) |
| KR (2) | KR20220146656A (https=) |
| CN (2) | CN120478602A (https=) |
| AU (2) | AU2018372709B2 (https=) |
| BR (1) | BR112020007817A2 (https=) |
| CL (1) | CL2020001252A1 (https=) |
| CR (1) | CR20200202A (https=) |
| DO (1) | DOP2020000104A (https=) |
| EA (1) | EA202090971A1 (https=) |
| EC (1) | ECSP20026436A (https=) |
| IL (1) | IL274563B2 (https=) |
| JO (1) | JOP20200126B1 (https=) |
| MA (1) | MA50798A (https=) |
| MX (1) | MX2020005231A (https=) |
| PE (1) | PE20200847A1 (https=) |
| PH (1) | PH12020550795A1 (https=) |
| SG (1) | SG11202003687RA (https=) |
| UA (1) | UA127588C2 (https=) |
| WO (1) | WO2019103875A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020190591A1 (en) * | 2019-03-15 | 2020-09-24 | Eli Lilly And Company | Preserved formulations |
| MX2022009383A (es) * | 2020-01-30 | 2022-11-07 | Lilly Co Eli | Usos terapéuticos de dulaglutida. |
| JP2023525898A (ja) * | 2020-05-19 | 2023-06-19 | エフ． ホフマン－ラ ロシュ アーゲー | 非経口タンパク質溶液における可視粒子の形成を防止するためのキレート剤の使用 |
| CN117915939A (zh) | 2021-06-23 | 2024-04-19 | 伊莱利利公司 | 肠降血糖素类似物用于血糖控制和体重管理 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0116024A (pt) | 2000-12-07 | 2005-12-13 | Lilly Co Eli | Proteìna de fusão heteróloga e uso da mesma |
| MXPA05013565A (es) | 2003-06-12 | 2006-03-09 | Lilly Co Eli | Proteinas de fusion analogas al glp-1. |
| EA011166B1 (ru) | 2004-12-22 | 2009-02-27 | Эли Лилли Энд Компани | Композиции слитых белков-аналогов glp-1 |
| CN101730523A (zh) * | 2007-07-10 | 2010-06-09 | 伊莱利利公司 | GLP-1-Fc融合蛋白质制剂 |
| AR100639A1 (es) * | 2014-05-29 | 2016-10-19 | Hanmi Pharm Ind Co Ltd | Composición para tratar diabetes que comprende conjugados de análogos de insulina de acción prolongada y conjugados de péptidos insulinotrópicos de acción prolongada |
| WO2016168388A2 (en) | 2015-04-14 | 2016-10-20 | Palatin Technologies, Inc. | Therapies for obesity, diabetes and related indications |
| JP7191043B2 (ja) | 2017-06-01 | 2022-12-16 | イーライ リリー アンド カンパニー | 慢性腎疾患の治療のためのデュラグルチド |
-
2018
- 2018-11-13 MX MX2020005231A patent/MX2020005231A/es unknown
- 2018-11-13 KR KR1020227035115A patent/KR20220146656A/ko not_active Ceased
- 2018-11-13 PE PE2020000547A patent/PE20200847A1/es unknown
- 2018-11-13 CN CN202510640885.XA patent/CN120478602A/zh active Pending
- 2018-11-13 JP JP2020525974A patent/JP7221956B2/ja active Active
- 2018-11-13 US US16/763,269 patent/US11576950B2/en active Active
- 2018-11-13 PH PH1/2020/550795A patent/PH12020550795A1/en unknown
- 2018-11-13 MA MA050798A patent/MA50798A/fr unknown
- 2018-11-13 CN CN201880075369.5A patent/CN111356472A/zh active Pending
- 2018-11-13 AU AU2018372709A patent/AU2018372709B2/en active Active
- 2018-11-13 UA UAA202002355A patent/UA127588C2/uk unknown
- 2018-11-13 EA EA202090971A patent/EA202090971A1/ru unknown
- 2018-11-13 EP EP18812499.4A patent/EP3713593A2/en active Pending
- 2018-11-13 SG SG11202003687RA patent/SG11202003687RA/en unknown
- 2018-11-13 KR KR1020207014456A patent/KR102589234B1/ko active Active
- 2018-11-13 CR CR20200202A patent/CR20200202A/es unknown
- 2018-11-13 BR BR112020007817-4A patent/BR112020007817A2/pt not_active Application Discontinuation
- 2018-11-13 WO PCT/US2018/060716 patent/WO2019103875A2/en not_active Ceased
- 2018-11-13 IL IL274563A patent/IL274563B2/en unknown
-
2020
- 2020-05-12 CL CL2020001252A patent/CL2020001252A1/es unknown
- 2020-05-20 EC ECSENADI202026436A patent/ECSP20026436A/es unknown
- 2020-05-21 JO JOJO/P/2020/0126A patent/JOP20200126B1/ar active
- 2020-06-01 DO DO2020000104A patent/DOP2020000104A/es unknown
-
2022
- 2022-02-01 JP JP2022014339A patent/JP7818412B2/ja active Active
- 2022-05-18 AU AU2022203372A patent/AU2022203372B2/en active Active
-
2023
- 2023-01-04 US US18/149,982 patent/US20240189394A1/en active Pending
-
2024
- 2024-02-16 JP JP2024021637A patent/JP2024056908A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022062153A5 (https=) | ||
| JP2018111728A5 (https=) | ||
| JP2018138578A5 (https=) | ||
| JP2021502379A5 (https=) | ||
| ME01337B (me) | Tečni preparat fsh | |
| KR101420315B1 (ko) | 약학적 액제 조성물 | |
| JP2011515404A5 (https=) | ||
| RU2366450C1 (ru) | Средство для лечения тяжелых инфекционных заболеваний и смешанных инфекций | |
| CN111093625A (zh) | 达托霉素制剂 | |
| ZA202102986B (en) | Protein solution formulation containing high concentration of an anti-vegf antibody | |
| US20250302779A1 (en) | Stable aqueous hydroxycarbamide solution | |
| HRP20241022T1 (hr) | Formulacije ciklosporina za upotrebu u liječenju sindroma bronchiolitis obliterans (bos) | |
| EP2804597B1 (en) | Aqueous paracetamol composition for injection | |
| EP0630649A1 (en) | Combination of an inhibitor of inducible nitric oxide synthase (iNOS) and an antiinflammatory agent, e.g. a corticosteroid | |
| JP2018521139A (ja) | 急速な作用発現を得るための発作の治療における口腔投与のためのミダゾラム組成物 | |
| RU2417083C2 (ru) | Применение активаторов растворимой гуанилатциклазы для лечения острых и хронических легочных заболеваний | |
| JP2023510609A (ja) | Ｇｌｐ－１および／またはｇｌｐ－１類似体、ならびにインスリンおよび／またはインスリン類似体を含む併用療法 | |
| US20170312297A1 (en) | Long Acting Pharmaceutical Compositions For Hepatitis C | |
| JP2017528526A (ja) | α型インターフェロンを含有する安定したベンジルアルコールフリーの水溶液製剤 | |
| WO2023280150A1 (en) | Combination therapy for treatment of liver diseases | |
| JP2022536223A5 (https=) | ||
| JPS63303931A (ja) | 経鼻投与用成長ホルモン放出活性物質製剤 | |
| JP2007506683A (ja) | ヒト成長ホルモン剤およびその調整方法と使用方法 | |
| JP2009507850A5 (https=) | ||
| CN103520515A (zh) | 鼓槌石斛提取物及其医药用途 |